Paramount Capital Asset Management
Investments
42Portfolio Exits
22
Want to inform investors similar to Paramount Capital Asset Management about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Paramount Capital Asset Management Investments
42 Investments
Paramount Capital Asset Management has made 42 investments. Their latest investment was in Neose Technologies as part of their Private Equity - II on March 3, 2007.
Paramount Capital Asset Management Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
3/20/2007 | Private Equity - II | Neose Technologies | $43.26M | No | Abingworth, Baker Brothers Investments, BAM Elevate, Bellevue Asset Management, Bristol Capital Advisors, Domain Associates, Downsview Capital, Dp V Associates Lp, Iroquois Capital Group, Medical Strategy, MHR Fund Management, MPM Capital, Oppenheim Pramerica Asset Management, OrbiMed Advisors, Paramount Capital Asset Management, Potomac Capital Management, Tang Capital Management, and Visium Asset Management | |
2/19/2007 | Unattributed VC - II | Genelabs Technologies | $9.49M | Yes | ||
12/21/2006 | PIPE | RegeneRx Biopharmaceuticals | $9.55M | Yes | ||
11/24/2006 | PIPE - IV | |||||
11/13/2006 | PIPE |
Date | 3/20/2007 | 2/19/2007 | 12/21/2006 | 11/24/2006 | 11/13/2006 |
|---|---|---|---|---|---|
Round | Private Equity - II | Unattributed VC - II | PIPE | PIPE - IV | PIPE |
Company | Neose Technologies | Genelabs Technologies | RegeneRx Biopharmaceuticals | ||
Amount | $43.26M | $9.49M | $9.55M | ||
New? | No | Yes | Yes | ||
Co-Investors | Abingworth, Baker Brothers Investments, BAM Elevate, Bellevue Asset Management, Bristol Capital Advisors, Domain Associates, Downsview Capital, Dp V Associates Lp, Iroquois Capital Group, Medical Strategy, MHR Fund Management, MPM Capital, Oppenheim Pramerica Asset Management, OrbiMed Advisors, Paramount Capital Asset Management, Potomac Capital Management, Tang Capital Management, and Visium Asset Management | ||||
Sources |
Paramount Capital Asset Management Portfolio Exits
22 Portfolio Exits
Paramount Capital Asset Management has 22 portfolio exits. Their latest portfolio exit was Antares Pharma on May 24, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
5/24/2022 | Acq - P2P | 5 | |||
11/25/2019 | Acq - P2P | 5 | |||
6/24/2017 | Acq - P2P | 2 | |||
Date | 5/24/2022 | 11/25/2019 | 6/24/2017 | ||
|---|---|---|---|---|---|
Exit | Acq - P2P | Acq - P2P | Acq - P2P | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 5 | 5 | 2 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.